Patent issued to U-Iowa for mutant chicken pox virus

April 16, 2003

The University of Iowa Research Foundation has been issued a patent for the first-known mutant chicken pox virus. The initial discovery was made in 1998 by Charles Grose, M.D., UI professor of pediatrics and director of the UI Division of Pediatric Infectious Diseases, and Richard Santos, M.D., Ph.D., a graduate of the UI Medical Scientist Training Program and now a resident in internal medicine at Washington University in St. Louis. The U.S. Patent 6,528,066 was issued on March 4.

The patent is useful for the potential development of a new diagnostic test for chicken pox, Grose said. The current chicken pox diagnostic test has been available since 1984 and cannot screen for the mutant form. Until Grose and Santos' finding, chicken pox was thought to be the same strain worldwide.

"The patent will help allow us to make an improved test which will detect all currently known forms of chicken pox -- the mutant form and the most commonly known form," Grose said. "It is generally difficult to patent a living organism such as a virus or a bacteria. The criteria include that there be no precedence for the finding and that it was not anticipated."

Chicken pox diagnostic tests are not routinely used in healthy people. The disease is noted and allowed to run its course. However, in children with existing serious illnesses such as cancer, any signs of infection are analyzed. If these children are found to have a verified case of chicken pox, they receive intravenous drugs to stop chicken pox from further developing.

Grose and Santos became involved in the mutant chicken pox investigation when a laboratory in Minnesota reported a child with cancer whose chicken pox resembled typical chicken pox but which did not test positive through the diagnostic test. The sample was sent to Grose's laboratory, where he and Santos analyzed it and found that one of the 70 genes in the virus had mutated. They later published their findings in the September 1998 issue of the journal Virology.

The patent also has implications for the possible development of a vaccine against the new strain of chicken pox. The current chicken pox vaccine came into use in 1995, before the discovery of the mutant form and thus may offer protection only against the previously known, common form. In developing the vaccine, approximately 6,000 children in Europe, Japan and the United States with chicken pox were analyzed between 1985 and 1995, and no mutant virus was seen at that time.

"One reason chicken pox was believed to be a perfect disease against which to make a vaccine was that it was thought to be the same virus all around the world," Grose said. "However, no one can be sure if the current chicken pox vaccine will be entirely protective against the mutant virus should it become more widely distributed in the population."

The current chicken pox vaccine is recommended for children between ages 1 and 2 but required only in some states.

In 2000, the National Virology Laboratory in Canada contacted Grose when the mutant chicken pox strain that he and Santos had identified was found in another patient. That finding suggested that the mutant form was contagious, rather than being a second, isolated case of the chicken pox having mutated on its own.

"The fact that the mutation was found a second time in the same site in the same gene but in a different person made us think that it is scientifically unlikely that in a virus containing 70 genes that the exact same mutation just happened to occur in two different people," Grose said. "We think that there are small populations of people in Canada and the United Sates who are carrying and passing on the mutant form of the virus."

Grose is collaborating with the Canadian laboratory to study groups of people who have active chicken pox to see if the mutant virus is more common than previously known.

"The broader implication of the mutant chicken pox strain relates to immunization goals to eliminate other diseases, such as measles," Grose said. "If chicken pox has this ability to mutate, which was not previously anticipated, then it means that it may be more difficult to eliminate as a disease. Mutated forms of chicken pox and other infectious diseases in the community may be more resistant to immunization."

Chicken pox, which also is known by its Latin name of varicella, is a misnomer. The disease has nothing to do with chickens, Grose said. Chicken pox comes from the Middle French term "chiche pois" -- which means "chickpea."

"In the Middle Ages, people in Europe made the distinction between chicken pox and smallpox. The French called chicken pox 'varicella' but the English decided on a new word that referred to the size of a chickpea. The lesions on the skin were thought to be the size of chickpeas. 'Chichepois' eventually became 'chicken pox,' " Grose said.

The chicken pox virus itself is the second-largest known virus in the world and is about half the size of the smallpox virus. Of the 70 genes contained in chicken pox, only a few of the genes are important for the ability of the virus to infect people.
University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at

STORY SOURCE: University of Iowa Health Science Relations, 5137 Westlawn, Iowa City, Iowa 52242-1178

CONTACT: Media: Becky Soglin (writer), 319-335-6660,

PHOTOS/GRAPHICS: A photo of Charles Grose, M.D., is available for downloading at

University of Iowa

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to